Beam Therapeutics is pioneering the use of CRISPR base editing to develop precision genetic medicines that treat disease, one letter at a time.

Beam Therapeutics Inc.
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://beamtx.com
Disease Focus
STOCK CODENon Listed
Address26 Landsdowne Street 2nd Floor, MA 02139CambridgeUnited States
26 Landsdowne Street 2nd Floor, MA 02139
Cambridge
United States
Contact Number
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://in.linkedin.com/company/beamtx” connections=”true” suffix=””]